← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Duquesne University Of The Holy Spirit
$6,156,044
Total funding
12
Grants
Funding over time
peak $3.2M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$5,526,675 · 8
DOE$449,618 · 2
NASA$179,751 · 2
By mechanism
—$6,156,044 · 12
Investigators at Duquesne University Of The Holy Spirit
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
LONG-ACTING NONOPIOID ANALGESIC (LANA) NANOMEDICINE FOR RAPID, SINGLE-DOSE, SUSTAINED PAIN CONTROL AND REHABILITATION SUPPORT AFTER NEUROMUSCULOSKELETAL INJURY. NEW AWARD.$1,499,801
· FY2020 · Defense Health Agency
NEURO-IMMUNO MODULATING ANALGESIC (NIMA) NANOMEDICINE PLATFORM FOR TREATMENT OF DIABETIC NEUROPATHY$1,187,157
· FY2020 · Defense Health Agency
RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION$700,000
· FY2024 · Defense Health Agency
EVIDENCE-BASED MENTAL HEALTH SERVICES FOR DISTRESSED POST-9/11 MILITARY FAMILY CAREGIVERS$655,102
· FY2016 · Department of the Army
DELIVERY OF MITOCHONDRIA USING EXTRACELLULAR VESICLES AS A NOVEL THERAPY FOR ALS$600,568
· FY2025 · Defense Health Agency
NANOIMAGING FOR NONINVASIVE MONITORING OF DONOR AND RECIPIENT IMMUNE SYSTEM CONTRIBUTION TO ACUTE AND CHRONIC REJECTION IN VCA. NEW AWARD.$499,828
· FY2020 · Defense Health Agency
NITRATE ENHANCED MICROBIAL CR(VI) REDUCTION NEW AWARDEE$449,972
· FY2008 · Department of Energy
A NOVEL GRAFT IMPLANTED MACROPHAGE-ENZYME RESPONSIVE IMMUNOSUPPRESSIVE THERAPY (MERIT) TO PREVENT CHRONIC REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION. NEW AWARD.$285,895
· FY2019 · Defense Health Agency
GENERATING SYSTEMIC ANTITUMOR IMMUNITY IN RENAL CELL CARCINOMA BY INTRATUMORAL INJECTION OF MULTIPLEXED ANTI-PD-1 ANTIBODY AND ADENOSINE DEAMINASE$98,324
· FY2018 · Department of the Army
CONTINUED INVESTIGATIONS OF ALTERNATIVE ANAEROBIC BIOGEOCHEMICAL REDOX CYCLES IN VOLCANIC HYPERSALINE ENVIRONMENTS: EARTH MARS AND EUROPA. A RE-RE$95,751
· FY2010 · National Aeronautics and Space Administration
CONTINUED INVESTIGATIONS OF "ALTERNATIVE" ANAEROBIC BIOGWOCHEMICAL REDOX CYCLES OF VOLCANIC HYPERSA$84,000
· FY2008 · National Aeronautics and Space Administration
NITRATE ENHANCED MICROBIAL CR(VI) REDUCTION$-354
· FY2013 · Department of Energy